// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
In the U.S. and around the world, quality standards developed by the U.S.
The opioid crisis in the U.S.
By Luc Besançon, Pharm.D. | Chief Executive Officer, International